These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28993940)

  • 1. A Randomized Crossover Study Evaluating the Use and Acceptability of the SILCS Diaphragm Compared to Vaginal Applicators for Vaginal Gel Delivery.
    Beksinska M; Greener R; Smit J; Maphumulo B; Mphili N; Kilbourne-Brook M; Coffey PS
    AIDS Behav; 2018 Jan; 22(1):127-132. PubMed ID: 28993940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Couples' acceptability of the SILCS diaphragm for microbicide delivery.
    Frezieres RG; Walsh T; Kilbourne-Brook M; Coffey PS
    Contraception; 2012 Jan; 85(1):99-107. PubMed ID: 22067809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An exploratory, randomized, crossover MRI study of microbicide delivery with the SILCS diaphragm compared to a vaginal applicator.
    Pentlicky S; Rosen M; Coffey PS; Kilbourne-Brook M; Shaunik A; Schreiber CA; Barnhart K
    Contraception; 2013 Feb; 87(2):187-92. PubMed ID: 22898358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
    Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D
    Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized, comparative safety study of a prefilled plastic and user-filled paper applicator with candidate microbicide tenofovir 1% gel.
    Cohen JA; Brache V; Foster J; Cochon L; Callahan M; Schwartz J
    Sex Transm Dis; 2013 Jun; 40(6):476-81. PubMed ID: 23677021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
    Joanis CL; Hart CW
    AIDS Behav; 2010 Jun; 14(3):600-6. PubMed ID: 20049522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use: Findings from the Carraguard Phase 3 Trial.
    Friedland BA; Stoner M; Chau MM; Plagianos MG; Govender S; Morar N; Altini L; Skoler-Karpoff S; Ahmed K; Ramjee G; Monedi C; Maguire R; Lähteenmäki P
    AIDS Behav; 2016 Nov; 20(11):2565-2577. PubMed ID: 26204987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa.
    Sahin-Hodoglugil NN; Montgomery E; Kacanek D; Morar N; Mtetwa S; Nkala B; Philip J; Ramjee G; Cheng H; van der Straten A; The Mira Team
    AIDS Care; 2011 Aug; 23(8):1026-34. PubMed ID: 21480005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of visual and ultraviolet light inspection versus DNA/protein biomarkers to assess product adherence with vaginal microbicide applicators.
    Thurman AR; Jacot TA; Kimble TD; Mauck C; Nelson A; Schwartz JL; Doncel GF
    Sex Transm Dis; 2014 Dec; 41(12):739-46. PubMed ID: 25581811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diaphragm and lubricant gel acceptance, skills and patterns of use among women in an effectiveness trial in Southern Africa.
    Montgomery ET; Blanchard K; Cheng H; Chipato T; de Bruyn G; Ramjee G; Padian N; van der Straten A;
    Eur J Contracept Reprod Health Care; 2009 Dec; 14(6):410-9. PubMed ID: 19929644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of microbicide gel adherence monitoring methods.
    Moench TR; O'Hanlon DE; Cone RA
    Sex Transm Dis; 2012 May; 39(5):335-40. PubMed ID: 22504592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States.
    Montgomery ET; Noguchi LM; Dai JY; Pan J; Biggio J; Hendrix C; Isaacs K; Watts DH; Schwartz JL; Piper J; Beigi R
    AIDS Behav; 2018 Feb; 22(2):402-411. PubMed ID: 28550377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design aspects of vaginal applicators that influence acceptance among target users.
    Bakke AJ; Zaveri T; Higgins MJ; Ziegler GR; Hayes JE
    Sci Rep; 2021 May; 11(1):9802. PubMed ID: 33963262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of treatment assignment on intravaginal cleansing in a randomized study of the diaphragm with candidate microbicide.
    Penman-Aguilar A; Legardy-Williams J; Turner AN; Rabozakandriana TO; Williams D; Razafindravoavy S; Behets F; Van Damme K; Jamieson DJ
    J Womens Health (Larchmt); 2011 Feb; 20(2):187-95. PubMed ID: 21314445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms.
    Weinrib R; Browne EN; Shapley-Quinn MK; van der Straten A; Beksinska M; Mgodi N; Musara P; Mphili N; Schwartz JL; Ju S; Hanif H; Montgomery ET;
    AIDS Behav; 2020 Feb; 24(2):637-647. PubMed ID: 31254190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal vaginal applicator for the uniform distribution of vaginal gel and cream formulations: a magnetic resonance imaging study.
    Omar RF; Trottier S; Brousseau G; Ouellet C; Danylo A; Ong T; Bergeron MG
    J Obstet Gynaecol Can; 2014 Jan; 36(1):42-50. PubMed ID: 24444286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming recruitment challenges: lessons learned from a safety and feasibility study of a diaphragm/microbicide combination in South Africa.
    Guest G; Severy L; von Mollendorf C; Van Damme L
    J Acquir Immune Defic Syndr; 2007 Aug; 45(4):481-2. PubMed ID: 17622839
    [No Abstract]   [Full Text] [Related]  

  • 18. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial.
    Barnhart KT; Rosenberg MJ; MacKay HT; Blithe DL; Higgins J; Walsh T; Wan L; Thomas M; Creinin MD; Westhoff C; Schlaff W; Archer DF; Ayers C; Kaunitz A; Das S; Moench TR
    Obstet Gynecol; 2007 Sep; 110(3):577-86. PubMed ID: 17766603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
    Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG
    Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
    Kilmarx PH; Blanchard K; Chaikummao S; Friedland BA; Srivirojana N; Connolly C; Witwatwongwana P; Supawitkul S; Mock PA; Chaowanachan T; Tappero J
    Sex Transm Dis; 2008 Mar; 35(3):226-32. PubMed ID: 18490865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.